Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.

Chen D, Riesbeck K, McVey JH, Kemball-Cook G, Tuddenham EG, Lechler RI, Dorling A.

Xenotransplantation. 2001 Nov;8(4):258-65.

PMID:
11737851
2.

Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins.

Chen D, Riesbeck K, Kemball-Cook G, McVey JH, Tuddenham EG, Lechler RI, Dorling A.

Transplantation. 1999 Feb 15;67(3):467-74.

PMID:
10030296
3.

Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.

Jiang R, Wang NP, Tanaka KA, Levy JH, Guyton RA, Zhao ZQ, Vinten-Johansen J.

J Surg Res. 2011 Aug;169(2):319-27. doi: 10.1016/j.jss.2010.01.041. Epub 2010 Feb 23.

4.

Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis.

Riesbeck K, Chen D, Kemball-Cook G, McVey JH, George AJ, Tuddenham EG, Dorling A, Lechler RI.

Circulation. 1998 Dec 15;98(24):2744-52.

5.

Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.

Kopp CW, Siegel JB, Hancock WW, Anrather J, Winkler H, Geczy CL, Kaczmarek E, Bach FH, Robson SC.

Transplantation. 1997 Mar 15;63(5):749-58.

PMID:
9075849
6.

Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.

Ollivier V, Chabbat J, Herbert JM, Hakim J, de Prost D.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1374-81.

7.

Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface.

Riesbeck K, Dorling A, Kemball-Cook G, McVey JH, Jones M, Tuddenham EG, Lechler RI.

Thromb Haemost. 1997 Dec;78(6):1488-94.

PMID:
9423800
8.

Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins.

Chen D, Riesbeck K, McVey JH, Kemball-Cook G, Tuddenham EG, Lechler RI, Dorling A.

Transplantation. 1999 Sep 27;68(6):832-9.

PMID:
10515384
9.

Factors in xenograft rejection.

Robson SC, Schulte am Esch J 2nd, Bach FH.

Ann N Y Acad Sci. 1999 Jun 18;875:261-76. Review.

PMID:
10415573
10.

Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells.

Shimizu T, Nishihira J, Watanabe H, Abe R, Honda A, Ishibashi T, Shimizu H.

J Biol Chem. 2004 Apr 2;279(14):13729-37. Epub 2004 Jan 21.

11.

Factor X fusion proteins: improved production and use in the release in vitro of biologically active hirudin from an inactive alpha-factor-hirudin fusion protein.

Guarna MM, Côté HC, Kwan EM, Rintoul GL, Meyhack B, Heim J, MacGillivray RT, Warren RA, Kilburn DG.

Protein Expr Purif. 2000 Nov;20(2):133-41.

PMID:
11049737
12.

Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.

Thomassen MC, Heinzmann AC, Herfs L, Hartmann R, Dockal M, Scheiflinger F, Hackeng TM, Rosing J.

J Thromb Haemost. 2015 Jan;13(1):92-100. doi: 10.1111/jth.12766. Epub 2014 Nov 29.

13.

FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834.

McLean K, Schirm S, Johns A, Morser J, Light DR.

Thromb Res. 2001 Aug 15;103(4):281-97.

PMID:
11562339
14.
15.

Role of exosite binding modulators in the inhibition of Fxa by TFPI.

Peraramelli S, Thomassen S, Heinzmann A, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M, Rosing J.

Thromb Haemost. 2016 Mar;115(3):580-90. doi: 10.1160/TH15-04-0354. Epub 2015 Nov 26.

PMID:
26607136
16.

Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.

Ghosh S, Ezban M, Persson E, Pendurthi U, Hedner U, Rao LV.

J Thromb Haemost. 2007 Feb;5(2):336-46. Epub 2006 Nov 9.

17.

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.

Santamaria S, Reglińska-Matveyev N, Gierula M, Camire RM, Crawley JTB, Lane DA, Ahnström J.

J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.

18.

Molecular incompatibilities in hemostasis between swine and men--impact on xenografting.

Schulte am Esch J 2nd, Rogiers X, Robson SC.

Ann Transplant. 2001;6(3):12-6. Review.

PMID:
11899892
19.

Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction.

Busch G, Seitz I, Steppich B, Hess S, Eckl R, Schömig A, Ott I.

Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):461-6. Epub 2004 Nov 18.

20.

Role of nitric oxide in poly(I-C)-induced endothelial cell expression of leukocyte adhesion molecules.

Faruqi TR, Erzurum SC, Kaneko FT, DiCorleto PE.

Am J Physiol. 1997 Nov;273(5 Pt 2):H2490-7.

PMID:
9374789

Supplemental Content

Support Center